GTC
ODT

Ghost Tree Capital’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Ghost Tree Capital’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-65,000
Closed -$2.38M – 53
2019
Q2 		$2.38M Buy
+65,000
New +$1.56M 0.49% 40

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Ghost Tree Capital's ODT Position: Q3 2019 in Review

Ghost Tree Capital sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q3 2019, closing a stake of 65,000 shares — an estimated $2.38M sold.

Ghost Tree Capital first reported a position in ODT in Q2 2019 and held it in 1 quarter. The position peaked at $2.38M in Q2 2019. 82 funds tracked by Wall St. Rank hold ODT as of Q3 2019.

  • Ghost Tree Capital reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Ghost Tree Capital sold 65,000 Odonate Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $2.38M.
  • Ghost Tree Capital first reported a position in Odonate Therapeutics, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Ghost Tree Capital's Odonate Therapeutics, Inc. Common Stock position peaked at $2.38M in Q2 2019.
  • 82 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Ghost Tree Capital's 13F filing for Q3 2019, filed 14 Nov 2019.